← Return to Transplant: No or Few Antibodies after COVID Vaccination

Discussion

Transplant: No or Few Antibodies after COVID Vaccination

Transplants | Last Active: Mar 7, 2022 | Replies (193)
Comment receiving replies
@athenalee

Hello @barbtc. There is an ongoing study that John Hopkins is conducting on transplant recipient development of antibodies following Covid vaccinations. Results from study participants receiving the third shot showed some development, but it widely varies depending on several variables. Here’s a link to the study:
https://transplantvaccine.org/

The most recent results were presented in the July 8 webinar, which is posted- https://transplantvaccine.org/study-results-and-webinars/

John Hopkins is also studying other potential ways the vaccine may help us build immunity, including B cells snd memory cells.

Jump to this post

Replies to "Hello @barbtc. There is an ongoing study that John Hopkins is conducting on transplant recipient development..."
zon | @zon | Sep 9, 2021

I got my results from John Hopkins blood 🩸 work today. I had my 3rd shot a week ago. My first two shots I got zero antibodies. Then retested at 3 months I had 48 and then one month later I had 40. The goal was to get to 2,500. I was not expecting today’s results. I got greater then 2,500. That’s doesn’t mean I’m protected. Still going to continue doing what I’m doing while they continue to study this. But it’s nice to get some good news. I’m hoping correct strength of meds a key to way of getting greater protection. Wish everyone else same success on boosters.

This message came with results. Antibodies against the SARS-CoV-2 spike protein receptor binding
domain (RBD) were detected. It is yet undetermined what level of
antibody to SARS-CoV-2 spike protein correlates to immunity against
developing symptomatic SARS-CoV-2 disease. Studies are underway to
measure the quantitative levels of specific SARS-CoV-2 antibodies
following vaccination. Such studies will provide valuable insights
into the correlation between protection from vaccination and
antibody levels.
Positive
Roche Elecsys Anti-SARS-CoV-2 S

VIEW AND REPLY